Work

Sotaglif lozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes Diabetes Care 2015;38:1181–1188 | DOI: 10.2337/dc14-2806 OBJECTIVE